Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01002456 · ClinicalTrials.gov registry record · NA
Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT01002456 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 220 participants.
The verdict
NCT01002456, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison samples. The setting is VA sites, with intervention directed at the pharmacy.
Interventions
- OTHER Level 1: (provide site-specifi information)
- OTHER Level 2 (Provide site- and patient-specific information)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01002456
The ClinicalTrials.gov registry entry for NCT01002456 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Level 1: (provide site-specifi information) is the first listed.
NCT01002456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01002456 about?
NCT01002456 is a clinical study titled "Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison". The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison ...
What is the current status of trial NCT01002456?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2009-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01002456?
The interventions under investigation include: Level 1: (provide site-specifi information) (OTHER), Level 2 (Provide site- and patient-specific information) (OTHER).
Who is sponsoring clinical trial NCT01002456?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.